Patent details

EP3116507 Title: COMPOUNDS FOR ORAL TREATMENT OF BRAIN TUMORS

Basic Information

Publication number:
EP3116507
PCT Application Number:
US2015019658
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157607946
PCT Publication Number:
WO2015138420
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS FOR ORAL TREATMENT OF BRAIN TUMORS
French Title of Invention:
COMPOSÉS POUR LE TRAITEMENT DE TUMEURS DU CERVEAU PAR VOIE ORALE
German Title of Invention:
VERBINDUNGEN ZUR ORALEN BEHANDLUNG VON HIRNTUMOREN
SPC Number:

Dates

Filing date:
10/03/2015
Grant date:
26/05/2021
EP Publication Date:
18/01/2017
PCT Publication Date:
17/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2021
EP B1 Publication Date:
26/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/03/2022
Expiration date:
10/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/05/2021
 
 

Name:
Kadmon Corporation, LLC
Address:
450 East 29th Street, New York, NY 10016, United States (US)

Inventor

Name:
WAKSAL, Samuel, D.
Address:
United States (US)

Priority

Priority Number:
201461950707 P
Priority Date:
10/03/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/517; A61K 31/495; A61K 31/395; A61P 35/00; A61P 35/04; A61P 25/00; A61P 43/00; A61K 9/00; A61K 45/06; C07D 403/12;

Publication

European Patent Bulletin

Issue number:
202121
Publication date:
26/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages